Is Venous Thromboembolism a Chronic Inflammatory Disease?

被引：18
作者：
Piazza, Gregory [1 ]
Ridker, Paul M. [1 ,2 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent,Dept Med, Boston, MA 02115 USA
来源：
CLINICAL CHEMISTRY | 2015年 / 61卷 / 02期
关键词：
RHEUMATOID-ARTHRITIS; LONG-TERM; THROMBOSIS; RISK; PREVENTION; ROSUVASTATIN; RATIONALE; DURATION; THERAPY; EVENTS;
D O I：
10.1373/clinchem.2014.234088
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：313 / 316
页数：4
相关论文
共 20 条
  • [1] Intertwining of thrombosis and inflammation in atherosclerosis
    Croce, Kevin
    Libby, Peter
    [J]. CURRENT OPINION IN HEMATOLOGY, 2007, 14 (01) : 55 - 61
  • [2] Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis
    Dessein, PH
    Joffe, BI
    Singh, S
    [J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 (03) : R634 - R643
  • [3] Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis
    Everett, Brendan M.
    Pradhan, Aruna D.
    Solomon, Daniel H.
    Paynter, Nina
    MacFadyen, Jean
    Zaharris, Elaine
    Gupta, Milan
    Clearfield, Michael
    Libby, Peter
    Hasan, Ahmed A. K.
    Glynn, Robert J.
    Ridker, Paul M.
    [J]. AMERICAN HEART JOURNAL, 2013, 166 (02) : 199 - +
  • [4] C-reactive protein and venous thromboembolism A prospective investigation in the ARIC cohort
    Folsom, Aaron R.
    Lutsey, Pamela L.
    Astor, Brad C.
    Cushman, Mary
    [J]. THROMBOSIS AND HAEMOSTASIS, 2009, 102 (04) : 615 - 619
  • [5] A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
    Glynn, Robert J.
    Danielson, Eleanor
    Fonseca, Francisco A. H.
    Genest, Jacques
    Gotto, Antonio M., Jr.
    Kastelein, John J. P.
    Koenig, Wolfgang
    Libby, Peter
    Lorenzatti, Alberto J.
    MacFadyen, Jean G.
    Nordestgaard, Borge G.
    Shepherd, James
    Willerson, James T.
    Ridker, Paul M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) : 1851 - 1861
  • [6] Optimal Duration of Anticoagulation After Venous Thromboembolism
    Goldhaber, Samuel Z.
    Piazza, Gregory
    [J]. CIRCULATION, 2011, 123 (06) : 664 - 667
  • [7] Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients
    Hjeltnes, G.
    Hollan, I.
    Forre, O.
    Wiik, A.
    Mikkelsen, K.
    Agewall, S.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2011, 40 (06) : 422 - 427
  • [8] Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization
    Holmqvist, Marie E.
    Neovius, Martin
    Eriksson, Jonas
    Mantel, Angla
    Wallberg-Jonsson, Solveig
    Jacobsson, Lennart T. H.
    Askling, Johan
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (13): : 1350 - 1356
  • [9] Increased Rheumatoid Factor and Deep Venous Thrombosis: 2 Cohort Studies of 54628 Individuals from the General Population
    Meyer-Olesen, Christine L.
    Nielsen, Sune F.
    Nordestgaard, Borge G.
    [J]. CLINICAL CHEMISTRY, 2015, 61 (02) : 349 - 359
  • [10] Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study
    Nielsen, Sune F.
    Bojesen, Stig E.
    Schnohr, Peter
    Nordestgaard, Borge G.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
12